Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 11Peritoneal Neoplasms 9Colorectal Neoplasms 3Neoplasms 2Hyperthermia 2Glioma 2Glioblastoma 2Gastrointestinal Neoplasms 2Fallopian Tube Neoplasms 2Colonic Neoplasms 2Brain Neoplasms 2Adrenocortical Carcinoma 2Wilms Tumor 1Stomach Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Retroperitoneal Neoplasms 1Recurrence 1Pseudomyxoma Peritonei 1Postoperative Complications 1Peritoneal Cavity Cancer 1Oligodendroglioma 1Neuroblastoma 1Neoplasm, Residual 1Mesothelioma 1Lymphatic Metastasis 1High Grade Serous Ovarian 1Gliosarcoma 1Desmoplastic Small Round Cell Tumor 1Carcinoma, Ovarian Epithelial 1

Interventions

Oxaliplatin 1Leucovorin 1Fluorouracil 1Cytoreduction Surgical Procedures 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Peritoneal Cavity Cancer × Cytoreduction Surgical Procedures × Clear all
NCT00625092 2017-11-29

Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
17 enrolled

Peritoneal Cavity Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡